US6818209B1
(en)
*
|
1998-05-22 |
2004-11-16 |
Oxford Biomedica (Uk) Limited |
Retroviral delivery system
|
US20040076613A1
(en)
*
|
2000-11-03 |
2004-04-22 |
Nicholas Mazarakis |
Vector system
|
US20070213290A1
(en)
*
|
1996-10-17 |
2007-09-13 |
Kingsman Alan J |
Neurite regeneration
|
US7635687B2
(en)
*
|
1997-06-04 |
2009-12-22 |
Oxford Biomedica (Uk) Limited |
Vector system
|
AU747438B2
(en)
*
|
1997-09-24 |
2002-05-16 |
Regents Of The University Of California, The |
Non-primate lentiviral vectors and packaging systems
|
GB2334257B
(en)
*
|
1997-12-22 |
2001-07-04 |
Oxford Biomedica Ltd |
Rectroviral vectors
|
EP1895010B1
(en)
*
|
1997-12-22 |
2011-10-12 |
Oxford Biomedica (UK) Limited |
Equine infectious anaemia virus (eiav) based vectors
|
GB9803351D0
(en)
*
|
1998-02-17 |
1998-04-15 |
Oxford Biomedica Ltd |
Anti-viral vectors
|
WO2000040741A2
(en)
*
|
1999-01-07 |
2000-07-13 |
The Government Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services, The National Institutes Of Health |
Lentivirus vector system
|
US6790657B1
(en)
|
1999-01-07 |
2004-09-14 |
The United States Of America As Represented By The Department Of Health And Human Services |
Lentivirus vector system
|
AU3893000A
(en)
*
|
1999-03-16 |
2000-10-04 |
Dana-Farber Cancer Institute, Inc. |
Lentiviral vector system for high quantity screening
|
CN1173036C
(zh)
*
|
1999-04-21 |
2004-10-27 |
卫生部艾滋病预防与控制中心 |
马传染性贫血病毒驴白细胞弱毒疫苗株的全长基因序列
|
DE60038567T2
(de)
|
1999-10-22 |
2009-05-14 |
Sanofi Pasteur Ltd., Toronto |
Modifiziertes gp100 und dessen verwendung
|
CN1321182C
(zh)
*
|
1999-12-30 |
2007-06-13 |
卫生部艾滋病预防与控制中心 |
马传染性贫血病毒代表毒株的全基因克隆及其应用
|
GB0009760D0
(en)
*
|
2000-04-19 |
2000-06-07 |
Oxford Biomedica Ltd |
Method
|
DE60124899T2
(de)
*
|
2000-05-10 |
2007-08-16 |
Sanofi Pasteur Ltd., Toronto |
Durch mage minigene kodierte immunogene polypeptide und ihre verwendungen
|
EP1345622A2
(en)
*
|
2000-09-09 |
2003-09-24 |
Akzo Nobel N.V. |
Eiav chimeric vaccine and diagnostic
|
GB0024550D0
(no)
*
|
2000-10-06 |
2000-11-22 |
Oxford Biomedica Ltd |
|
US7575924B2
(en)
*
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
AU2001297735A1
(en)
*
|
2000-11-16 |
2002-10-15 |
Rigel Pharmaceuticals, Inc. |
In vitro transcribed retroviral genomes, methods for their production and methods of use
|
US6712612B1
(en)
|
2000-12-12 |
2004-03-30 |
Genecure Llc |
Safe and stable retroviral helper cell line and related compositions and methods
|
EP1373536B9
(en)
|
2001-03-13 |
2009-09-02 |
Novartis AG |
Lentiviral packaging constructs
|
US7211247B2
(en)
*
|
2001-04-09 |
2007-05-01 |
University Of Southern California |
Lentivirus vectors for gene transfer to alveolar epithelial cells
|
CA2344208A1
(en)
|
2001-04-30 |
2002-10-30 |
Oxford Biomedica (Uk) Limited |
Method
|
CA2456169C
(en)
|
2001-08-02 |
2012-05-22 |
Didier Trono |
Methods and compositions relating to improved lentiviral vector production systems
|
AU2002343458B2
(en)
|
2001-10-02 |
2008-03-20 |
Institut Clayton De La Recherche |
Methods and compositions relating to restricted expression lentiviral vectors and their applications
|
WO2003048705A1
(en)
|
2001-12-05 |
2003-06-12 |
The Regents Of The University Of California |
Robotic microscopy systems
|
ATE517122T1
(de)
|
2002-04-09 |
2011-08-15 |
Sanofi Pasteur Ltd |
Modifizierte cea-nukleinsäure und entsprechende expressionsvektoren
|
KR101002955B1
(ko)
*
|
2002-04-26 |
2010-12-21 |
인스티튜트 클레이톤 드 라 리쎄르셰 |
개선된 키메라 당단백질 및 슈도타입 렌티바이러스 벡터
|
AU2003291426A1
(en)
*
|
2002-11-12 |
2004-06-03 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Human Services, The National Institutes Of Health |
Gp64-pseudotyped vectors and uses thereof
|
DK1563069T3
(da)
*
|
2002-11-22 |
2012-07-23 |
Inst Clayton De La Rech |
Sammensætninger og systemer til genregulering
|
EP1594459B1
(en)
|
2002-12-30 |
2010-02-17 |
Angiotech International Ag |
Drug delivery from rapid gelling polymer composition
|
US8026819B2
(en)
*
|
2005-10-02 |
2011-09-27 |
Visible Assets, Inc. |
Radio tag and system
|
AU2004269233A1
(en)
*
|
2003-08-29 |
2005-03-10 |
Kaneka Corporation |
Method of constructing transgenic bird using lentivirus vector and transgenic bird obtained thereby
|
BRPI0415199A
(pt)
*
|
2003-10-08 |
2006-12-05 |
Sanofi Pasteur Inc |
vetor cea/b7 modificado
|
AU2005327198B2
(en)
*
|
2004-07-09 |
2011-03-31 |
University Of North Carolina At Chapel Hill |
Viral adjuvants
|
US8486420B2
(en)
*
|
2005-02-15 |
2013-07-16 |
The University Of North Carolina At Chapel Hill |
Live virus vaccines
|
WO2007089780A2
(en)
*
|
2006-01-30 |
2007-08-09 |
Licentia, Ltd. |
Bmx/etk tyrosine kinase gene therapy materials and methods
|
WO2008044869A1
(en)
*
|
2006-10-10 |
2008-04-17 |
Viromed Co., Ltd. |
Expression vectors with improved safety
|
US20100092435A1
(en)
|
2006-12-07 |
2010-04-15 |
Emmanuel Jacques Henri Joseph Wiertz |
Use of a varicellovirus tap-inhibitor for the induction of tumor-or virus-specific immunity against teipp
|
CN101705246B
(zh)
*
|
2007-04-29 |
2012-06-27 |
中国农业科学院哈尔滨兽医研究所 |
慢病毒基因转移载体、其制备方法和应用
|
JP2011500036A
(ja)
|
2007-10-15 |
2011-01-06 |
ザ ユニバーシティー オブ クイーンズランド |
構築物系およびその使用
|
JP2011503207A
(ja)
|
2007-11-16 |
2011-01-27 |
サン ディエゴ ステート ユニバーシティ リサーチ ファウンデーション |
循環系細胞におけるpim−1活性を操作するための組成物および方法
|
WO2010087702A1
(en)
|
2009-01-30 |
2010-08-05 |
Stichting Katholieke Universiteit |
TET2 gene as a marker for diagnosing a myelodysuplastic syndrome (MDS) or an acute myeloid leukemia (AML) and determining the prognosis in a subject
|
KR101904224B1
(ko)
|
2009-02-03 |
2018-10-04 |
코닌클리즈케 네덜란드세 아카데미 반 베텐샤펜 |
상피 줄기 세포용 배양 배지 및 상기 줄기 세포를 포함하는 오르가노이드
|
US9752124B2
(en)
|
2009-02-03 |
2017-09-05 |
Koninklijke Nederlandse Akademie Van Wetenschappen |
Culture medium for epithelial stem cells and organoids comprising the stem cells
|
EP2412800A1
(en)
|
2010-07-29 |
2012-02-01 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Liver organoid, uses thereof and culture method for obtaining them
|
CN101532031B
(zh)
*
|
2009-03-03 |
2011-04-20 |
上海吉盛制药技术有限公司 |
非整合慢病毒载体系统及其制备与应用
|
EP2478101A1
(en)
|
2009-09-16 |
2012-07-25 |
Stichting Het Nederlands Kanker Instituut |
Fra-1 target genes as drug targets for treating cancer
|
EP2305717A1
(en)
|
2009-09-21 |
2011-04-06 |
Koninklijke Nederlandse Akademie van Wetenschappen |
Inhibiting TNIK for treating colon cancer
|
EP2319918B1
(en)
*
|
2009-11-10 |
2013-01-16 |
Centre National De La Recherche Scientifique |
Lentiviral-based vector and its use in directed evolution of genomic regions, genes and polynucleotides
|
US20120027725A1
(en)
*
|
2009-11-30 |
2012-02-02 |
Galvin Jeffrey A |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules to treat liver cancer
|
US9795658B2
(en)
|
2010-04-20 |
2017-10-24 |
Admedus Vaccines Pty Ltd |
Expression system for modulating an immune response
|
CA2805170C
(en)
|
2010-07-12 |
2021-09-21 |
Fatima Bosch Tubert |
Gene therapy composition for use in diabetes treatment
|
WO2012047093A1
(en)
|
2010-10-05 |
2012-04-12 |
Academisch Ziekenhuis Bij De Universiteit Van Amsterdam |
Treatment of the sjögren's syndrome
|
EP2465928A1
(en)
|
2010-12-16 |
2012-06-20 |
Academisch Medisch Centrum bij de Universiteit van Amsterdam |
Treatment of Th17-mediated diseases
|
CA2789539A1
(en)
|
2011-09-12 |
2013-03-12 |
International Aids Vaccine Initiative |
Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
|
US9402894B2
(en)
|
2011-10-27 |
2016-08-02 |
International Aids Vaccine Initiative |
Viral particles derived from an enveloped virus
|
US9347065B2
(en)
|
2012-03-29 |
2016-05-24 |
International Aids Vaccine Initiative |
Methods to improve vector expression and genetic stability
|
WO2014003553A1
(en)
|
2012-06-27 |
2014-01-03 |
Arthrogen B.V. |
Combination for treating an inflammatory disorder
|
JP6373833B2
(ja)
|
2012-07-12 |
2018-08-15 |
プロキューアール・セラピューティクス・セカンド・ベスローテン・フェンノートシャップProQR Therapeutics II B.V. |
生細胞に存在する標的rna分子の配列を変化させるためのオリゴヌクレオチド
|
EP2692868A1
(en)
|
2012-08-02 |
2014-02-05 |
Universitat Autònoma De Barcelona |
Adeno-associated viral (AAV) vectors useful for transducing adipose tissue
|
US9730996B2
(en)
|
2012-10-24 |
2017-08-15 |
Texas Biomedical Research Institute |
Involucrin-driven retroviral expression cassettes encoding human immunodeficiency virus envelope glycoproteins
|
EP2970892A1
(en)
|
2013-03-15 |
2016-01-20 |
The Jackson Laboratory |
Isolation of non-embryonic stem cells and uses thereof
|
WO2015069469A1
(en)
|
2013-11-05 |
2015-05-14 |
Clontech Laboratories, Inc. |
Dry transfection compositions and methods for making and using the same
|
WO2015160928A2
(en)
|
2014-04-15 |
2015-10-22 |
University Of Virginia Patent Foundation |
Isolated t cell receptors and methods of use therefor
|
EP3031923A1
(en)
*
|
2014-12-11 |
2016-06-15 |
Institut Pasteur |
Lentiviral vector-based japanese encephalitis immunogenic composition
|
ES2900973T3
(es)
|
2015-01-07 |
2022-03-21 |
UNIV AUTòNOMA DE BARCELONA |
Constructo genético de vector individual que comprende genes de insulina y glucoquinasa
|
JP7089469B2
(ja)
|
2015-10-23 |
2022-06-22 |
ザ ジャクソン ラボラトリー |
眼神経変性障害(例えば緑内障)の処置及び予防における使用のためのニコチンアミド
|
JP7118887B2
(ja)
|
2015-11-23 |
2022-08-16 |
ノバルティス アーゲー |
最適化されたレンチウイルス移入ベクターおよびその使用
|
US10596248B2
(en)
|
2015-12-09 |
2020-03-24 |
Jingang Medicine (Australia) Pty Ltd |
Immunomodulating composition for treatment
|
EP4099015A1
(en)
|
2016-06-10 |
2022-12-07 |
Gadeta B.V. |
Novel method for identifying deltat-cell (or gammat-cell) receptor chains or parts thereof that mediate an anti-tumour or an anti-infective response
|
WO2018018082A1
(en)
|
2016-07-26 |
2018-02-01 |
The Australian National University |
Immunostimulatory compositions and uses therefor
|
CA3050917A1
(en)
|
2017-01-30 |
2018-08-02 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Recombinant virus vectors for the treatment of glycogen storage disease
|
WO2018215613A1
(en)
|
2017-05-24 |
2018-11-29 |
Universitat Autonoma De Barcelona |
Viral expression construct comprising a fibroblast growth factor 21 (fgf21) coding sequence
|
US11597917B2
(en)
|
2017-07-06 |
2023-03-07 |
The Medical College Of Wisconsin, Inc. |
In vitro and in vivo enrichment strategy targeting lymphocytes derived from vector transduced HSCs for therapy of disorders
|
EP3732285A1
(en)
|
2017-12-28 |
2020-11-04 |
Tract Pharmaceuticals, Inc. |
Stem cell culture systems for columnar epithelial stem cells, and uses related thereto
|
WO2019219979A1
(en)
|
2018-05-18 |
2019-11-21 |
Umc Utrecht Holding B.V. |
Compositions and methods for cell targeting therapies
|
WO2020018715A1
(en)
|
2018-07-17 |
2020-01-23 |
Massachusetts Institute Of Technology |
Soluble multimeric immunoglobulin-scaffold based fusion proteins and uses thereof
|
KR20210096128A
(ko)
|
2018-11-26 |
2021-08-04 |
유니버시타트 아우토노마 데 바르셀로나 |
섬유아세포 성장 인자 21(fgf21) 유전자 요법
|
SG11202104337PA
(en)
|
2018-11-26 |
2021-05-28 |
Massachusetts Inst Technology |
Compositions and methods for immune tolerance
|
JP2022534733A
(ja)
|
2019-05-31 |
2022-08-03 |
ウニベルシダッド アウトノマ デ バルセロナ |
インスリン遺伝子治療
|
AU2021264465A1
(en)
|
2020-04-27 |
2022-12-15 |
University Of Iowa Research Foundation |
Compositions and methods for the treatment of cystic fibrosis
|
AU2021281506A1
(en)
|
2020-05-26 |
2023-02-02 |
Universitat Autònoma De Barcelona |
Fibroblast growth factor 21 (FGF21) gene therapy for central nervous system disorders
|
EP4158030A1
(en)
*
|
2020-05-27 |
2023-04-05 |
The Medical College of Wisconsin, Inc. |
Improved lentiviral vector transfer plasmid and methods of use
|
EP4259777A1
(en)
|
2020-12-10 |
2023-10-18 |
Sarepta Therapeutics, Inc. |
Suspension mode seed train development for adherent cells
|
CA3206590A1
(en)
|
2021-01-30 |
2022-08-04 |
Maria Fatima Bosch Tubert |
Gene therapy for monogenic diabetes
|
WO2022221462A1
(en)
|
2021-04-13 |
2022-10-20 |
Kriya Therapeutics, Inc. |
Vector constructs for delivery of nucleic acids encoding therapeutic vlcad or mcad and methods of using the same
|
EP4089171A1
(en)
|
2021-05-12 |
2022-11-16 |
Fundación del Sector Público Estatal Centro Nacional de Investigaciones Oncológicas Carlos III (F.S.P. CNIO) |
Recombinant tert-encoding viral genomes and vectors
|
WO2022258606A1
(en)
|
2021-06-07 |
2022-12-15 |
Gadeta B.V. |
Delta T-cell or Gamma T-cell receptor chains or parts thereof that mediate an anti-tumour or anti-infective response
|
EP4370677A1
(en)
|
2021-07-16 |
2024-05-22 |
Academisch Ziekenhuis Leiden h.o.d.n. LUMC |
Oligonucleotide for inhibiting quaking activity
|
WO2023212683A1
(en)
|
2022-04-29 |
2023-11-02 |
Kriya Therapeutics, Inc. |
Insulin and glucokinase gene therapy compositions and its use for treating diabetes
|
WO2023227594A1
(en)
|
2022-05-24 |
2023-11-30 |
Gadeta Bv |
Novel deltat-cell receptor chains, gammat-cell receptor chains, or parts thereof
|
WO2023237541A1
(en)
|
2022-06-07 |
2023-12-14 |
Gadeta B.V. |
Delta t-cell or gamma t-cell receptor chains or parts thereof that mediate an anti-tumour or anti-infective response
|
WO2024013401A1
(en)
|
2022-07-15 |
2024-01-18 |
Gadeta B.V. |
Novel method for identifying gamma t-cell (or delta t-cell) receptor chains (or gammadelta t-cell receptors) or fragments thereof that mediate an anti-tumour or an anti-infective response
|
WO2024052413A1
(en)
|
2022-09-07 |
2024-03-14 |
Universitat Autònoma De Barcelona |
Beta-hexosaminidase vectors
|
WO2024100136A1
(en)
|
2022-11-08 |
2024-05-16 |
Gadeta B.V. |
Novel method for obtaining gamma t-cell (or delta t-cell) receptor chains (or gamma delta t-cell receptors) or fragments thereof that mediate an anti-tumour or an anti-infective response
|